Hope, Awareness of Illness, and Coping in Schizophrenia Spectrum Disorders

2005 ◽  
Vol 193 (5) ◽  
pp. 287-292 ◽  
Author(s):  
Paul H. Lysaker ◽  
Kikuko Campbell ◽  
Jason K. Johannesen
Keyword(s):  
Schizophrenia Spectrum Disorders ◽  
Schizophrenia Spectrum ◽  
Spectrum Disorders ◽  
And Coping

Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study

2016 ◽  
Vol 46 (10) ◽  
pp. 2179-2188 ◽  
Author(s):  
E. Jung ◽  
M. Wiesjahn ◽  
H. Wendt ◽  
T. Bock ◽  
W. Rief ◽  
...  
Keyword(s):  
Social Support ◽  
Coping Strategies ◽  
Antipsychotic Medication ◽  
Structured Interview ◽  
Considerable Proportion ◽  
Schizophrenia Spectrum Disorders ◽  
Schizophrenia Spectrum ◽  
General Functioning ◽  
Spectrum Disorders ◽  
And Coping

BackgroundA considerable proportion of people with schizophrenia spectrum disorders do not take antipsychotic medication but seem to be functioning well. However, little is known about this group. To test the assumption that absence of medication is compensated for by more effective coping and increased social support, this study compared symptoms, functioning, coping strategies and social support in non-medicated and medicated individuals with schizophrenia spectrum disorders.MethodIn all, 48 participants with a DSM-IV schizophrenia spectrum disorder who were taking (n= 25) or not taking antipsychotic medication (n= 23) were included. Assessment consisted of self-ratings of symptoms, symptom-related distress and social support combined with a semi-structured interview that assessed general and social functioning, subjective evaluation of symptoms and coping strategies.ResultsSymptom severity and distress did not differ between the groups. However, the non-medicated participants had significantly higher levels of general functioning than medicated participants and a longer duration of being non-medicated was significantly associated with a higher level of general functioning. In contrast to the hypotheses, not taking medication was not associated with more effective coping strategies or with higher levels of social support. Medicated participants more frequently reported the use of professional help as a coping strategy.ConclusionsOur results corroborate previous studies finding improved functioning in individuals with schizophrenia spectrum disorders who do not take medication compared with those who take medication, but do not support the notion that this difference is explicable by better coping or higher levels of social support. Alternative explanations and avenues for research are discussed.

Are self-stigma and coping strategies interrelated in outpatients with schizophrenia spectrum disorders using the psychiatric medication? Cross-sectional study

2016 ◽  
Vol 33 (S1) ◽  
pp. S99-S100
Author(s):  
M. Holubova ◽  
J. Prasko ◽  
R. Hruby ◽  
K. Latalova ◽  
M. Slepecky ◽  
...  
Keyword(s):  
Coping Strategies ◽  
Mental Health Professionals ◽  
Psychiatric Medication ◽  
Schizophrenia Spectrum Disorders ◽  
High Positive Correlation ◽  
Schizophrenia Spectrum ◽  
Spectrum Disorders ◽  
Negative Coping ◽  
Self Instruction ◽  
And Coping

IntroductionSelf-stigma is the maladaptive psychosocial phenomenon that can affect the patient's self-image, may lead to dysphoria, social isolation, reduced adherence and quality of life. Maladaptive coping strategies may adversely disturb the overall functioning of psychiatric patients.ObjectivesThinking about coping strategies and self-stigma in practice may play a significant role in understanding patients with schizophrenia spectrum disorders, especially for mental health professionals. Focus on coping strategies could be a useful concept in supportive and educational therapy to help patients in using more adaptive coping strategies and decrease their self-stigma.AimsThe aim of this study was to determine the relation between coping strategies and the self-stigma among outpatients with schizophrenia and related disorders.MethodsStress Coping Style Questionnaire (SVF-78), Internalized Stigma of Mental Illness (ISMI) and severity of the disorder (measured by Clinical Global Impression objective and subjective form) were assessed.ResultsOne hundred and four patients suffering from schizophrenia (n = 67), schizoaffective disorder (n = 30), polymorphic psychotic disorder (n = 3), schizotypal disorder (n = 2) and delusional disorder (n = 2) were included in the study. The results showed that there was a high positive correlation between negative coping and self-stigma, and the negative correlation between positive strategies and the overall score of self-stigma. Stepwise regression analysis showed that negative coping (especially resignation), subjective severity SubjCGI and positive coping strategies (especially positive self-instruction) explains 52.8% of the overall score variance of self-stigma (Tables 1–3).ConclusionsThis study revealed that there is a connection between self-stigma and coping strategies in patients suffering from schizophrenia spectrum disorders.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Screening Adolescents for Schizophrenia-Spectrum Disorders

2000 ◽  
Author(s):  
B. Cornblatt ◽  
M. Obuchowski ◽  
S. Roberts ◽  
S. Pollack ◽  
L. Erienmeyer-Kimling
Keyword(s):  
Schizophrenia Spectrum Disorders ◽  
Schizophrenia Spectrum ◽  
Spectrum Disorders

Sleep and cognition in schizophrenia spectrum disorders: A systematic review protocol.

2020 ◽  
Author(s):  
Sean Carruthers ◽  
Gemma Brunetti ◽  
Susan Rossell
Keyword(s):  
Systematic Review ◽  
Mental Illnesses ◽  
Schizophrenia Spectrum Disorders ◽  
Systematic Review Protocol ◽  
Schizophrenia Spectrum Disorder ◽  
Schizophrenia Spectrum ◽  
Review Protocol ◽  
Spectrum Disorders ◽  
Sleep And Cognition ◽  
The Relationship

Schizophrenia spectrum disorders are chronic and debilitating mental illnesses characterised by both cognitive impairments and sleep deficits. In this systematic review protocol, we outline an approach to examine the available literature investigating the relationship between sleep and cognition in individuals with schizophrenia spectrum disorder.

scholarly journals Randomised controlled trial of Compensatory Cognitive Training and a Computerised Cognitive Remediation programme

Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Frances Dark ◽  
Ellie Newman ◽  
Victoria Gore-Jones ◽  
Veronica De Monte ◽  
Marta I. Garrido ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Randomised Controlled Trial ◽  
Outcome Measures ◽  
Cognitive Training ◽  
Controlled Trial ◽  
Schizophrenia Spectrum Disorders ◽  
Cognitive Interventions ◽  
Schizophrenia Spectrum ◽  
Spectrum Disorders ◽  
Randomised Controlled

Abstract Background Compensation and adaptation therapies have been developed to improve community functioning via improving neurocognitive abilities in people with schizophrenia. Various modes of delivering compensation and adaptation therapies have been found to be effective. The aim of this trial is to compare two different cognitive interventions, Compensatory Cognitive Training (CCT) and Computerised Interactive Remediation of Cognition–Training for Schizophrenia (CIRCuiTS). The trial also aims to identify if mismatch negativity (MMN) can predict an individual’s response to the compensation and adaptation programmes. Methods This study will use a randomised, controlled trial of two cognitive interventions to compare the impact of these programmes on measures of neurocognition and function. One hundred clinically stable patients aged between 18 and 65 years with a diagnosis of a schizophrenia spectrum disorder will be recruited. Participants will be randomised to either the CCT or the CIRCuiTS therapy groups. The outcome measures are neurocognition (BACS), subjective sense of cognitive impairment (SSTICS), social functioning (SFS), and MMN (measured by EEG) in people with schizophrenia spectrum disorders. Discussion This trial will determine whether different approaches to addressing the cognitive deficits found in schizophrenia spectrum disorders are of comparable benefit using the outcome measures chosen. This has implications for services where cost and lack of computer technology limit the implementation and dissemination of interventions to address cognitive impairment in routine practice. The trial will contribute to the emerging evidence of MMN as a predictor of response to cognitive interventions. Trial registration Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12618000161224. Registered on 2 February 2018. Protocol version: 4.0, 18 June 2018.

Sign in / Sign up

Export Citation Format

Share Document